Delivery Order SPE2DB20D3103-SPE2DB25FQ2F5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp valued at $26,378.33 for supply of Jardiance 25 mg tablets (90-count units). The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 6, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,578.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,721.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $4,976.53. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $61,893.35. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on a non-set-aside,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,540.20 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $12,877.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child delivery order issued under a larger contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count units) at a ceiling value of $49,619.13. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a competitive award with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,241.94 to AmerisourceBergen Drug Corp for supply of Jardiance 25 mg tablets (90-count packaging) with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2F5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $43,173.49 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle designated SPE2DX that runs through December 2026 and serves as the primary pharmaceutical supply mechanism for military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems through this expansive IDC platform. Jardiance, an oral diabetes medication, aligns with the company's established portfolio of specialty pharmaceuticals delivered under its DLA contracts. The contract demonstrates AmerisourceBergen's ongoing role as a primary supplier within the DLA's pharmaceutical supply chain, supporting Defense Health Agency and other federal healthcare stakeholders with time-sensitive medication deliveries for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.2k | 9/9/25 |